Core Viewpoint - Saratoga Investment Corp. is set to report its financial results for the fiscal quarter ended August 31, 2025, on October 7, 2025, with a conference call scheduled for October 8, 2025, to discuss these results [1][2]. Company Overview - Saratoga Investment Corp. is a specialty finance company that provides customized financing solutions to U.S. middle-market businesses [3]. - The company primarily invests in senior and unitranche leveraged loans and mezzanine debt, with a lesser focus on equity, to finance ownership changes, strategic acquisitions, recapitalizations, and growth initiatives [3]. - The objective of Saratoga Investment is to achieve attractive risk-adjusted returns through current income and long-term capital appreciation from its investments [3]. - The company is regulated as a business development company under the Investment Company Act of 1940 and is externally managed by Saratoga Investment Advisors, LLC [3]. - Saratoga Investment Corp. owns two active SBIC-licensed subsidiaries and manages a $650 million collateralized loan obligation (CLO) fund that is in wind-down, along with a joint venture fund that owns a $400 million CLO [3]. - The company holds 52% of the Class F and 100% of the subordinated notes of the CLO, as well as 87.5% of both the unsecured loans and membership interests of the joint venture [3].

Core Viewpoint - Ares Capital Corporation (ARCC) and Hercules Capital, Inc. (HTGC) are two prominent Business Development Companies (BDCs) with differing investment strategies, where ARCC targets middle-market firms and HTGC focuses on high-growth technology and life sciences sectors [1][2] Group 1: Ares Capital (ARCC) - ARCC's investments typically range from $30 million to $500 million, with power generation projects between $10 million and $200 million, offering customized financing solutions primarily in senior secured debt [3] - In the first half of 2025, ARCC experienced year-over-year growth in total investment income, driven by increased interest income and capital structuring service fees [4] - Over the past five years, ARCC's total investment income has grown at a CAGR of 14.4%, with gross investment commitments of $15.1 billion in 2024 and $6 billion in 2023 [5] - As of June 30, 2025, ARCC's diversified investment portfolio was valued at $27.9 billion across more than 560 companies, with significant investments in software & services (24%) and healthcare equipment & services (13%) [6] - Analysts have revised ARCC's earnings estimates downward, indicating a 13.7% decline for 2025 and a 0.9% decline for 2026 [12][15] - ARCC's stock is currently trading at a 12-month forward P/E of 10.40X, reflecting a premium valuation [20] Group 2: Hercules Capital (HTGC) - HTGC's investments generally range from $15 million to $40 million, focusing on structured debt with warrants and targeting companies with at least six months to one year of operational history [7] - In the first half of 2025, HTGC saw slight growth in total investment income and an increase in gross new debt and equity commitments [8] - Over the last decade, HTGC's total investment income has grown at a CAGR of 12.1%, with new debt and equity commitments of $2.6 billion in 2021 and $3.1 billion in 2022 [9] - As of June 30, 2025, HTGC's investment portfolio was valued at $4.2 billion, with 35% in software companies and 25% in drug discovery & development [11] - Analysts are more optimistic about HTGC's prospects, with a projected 4% decline in 2025 earnings but a 5% growth expected in 2026 [15] - HTGC is trading at a lower 12-month forward P/E of 9.66X compared to ARCC, making it a more attractive valuation [20][23] Group 3: Comparative Analysis - The operating environment is improving, positioning HTGC for long-term growth due to its focus on high-growth sectors, rising investment commitments, and projected earnings growth for 2026 [24] - ARCC's broader industry exposure makes it more susceptible to tariff-related risks, while its diversified portfolio offers income stability [25] - Both companies currently hold a Zacks Rank of 3 (Hold), indicating a neutral outlook [26]

Core Viewpoint - Saratoga Investment Corp. has declared a base quarterly dividend of $0.75 per share for the third quarter of fiscal 2026, maintaining a consistent dividend policy to provide attractive returns to shareholders [1][2]. Dividend Declaration - The declared dividends for the third quarter of fiscal 2026 are as follows: - September 2025: $0.25 per share, record date October 7, 2025, payment date October 23, 2025 - October 2025: $0.25 per share, record date November 4, 2025, payment date November 20, 2025 - November 2025: $0.25 per share, record date December 2, 2025, payment date December 18, 2025 [1][2]. Dividend Yield - The annualized dividend rate of $0.75 per share implies a 12.2% dividend yield based on the stock price of $24.54 as of September 9, 2025 [1]. Historical Dividend Distributions - The total dividend for fiscal year 2026 is projected to be $2.25 per share, with consistent quarterly distributions of $0.25 per share [3]. Company Overview - Saratoga Investment is a specialty finance company focused on providing customized financing solutions to U.S. middle-market businesses, primarily investing in senior and unitranche leveraged loans and mezzanine debt [5]. - The company is regulated as a business development company under the Investment Company Act of 1940 and is externally managed by Saratoga Investment Advisors, LLC [5]. - Saratoga Investment manages a $500 million collateralized loan obligation (CLO) fund and co-manages a joint venture fund with a $400 million CLO [5].

Group 1: Overview of Ares Capital Corporation (ARCC) - Ares Capital focuses on middle-market firms across various industries, providing debt financing ranging from $30 million to $500 million [6][9] - As of March 31, 2025, ARCC had a diversified investment portfolio of $27.1 billion across 566 portfolio companies, with significant investments in software & services (24%) and healthcare equipment & services (13%) [9][12] - In Q1 2025, ARCC reported a 4.4% year-over-year growth in total investment income, driven by increased interest income, but faced lower portfolio exits and gross commitments [7][12] Group 2: Overview of Hercules Capital, Inc. (HTGC) - Hercules Capital specializes in venture debt, targeting high-growth technology and life sciences sectors, with investments generally ranging from $15 million to $40 million [15][20] - As of March 31, 2025, HTGC had an investment portfolio of $3.9 billion, with 32% in software companies and 29% in drug discovery & development [20][23] - In Q1 2025, HTGC experienced a 2% decline in total investment income but recorded a rise in gross new debt and equity commitments [16][23] Group 3: Financial Performance and Growth Outlook - Ares Capital's total investment income has seen a CAGR of 14.4% over the last five years, with significant gross investment commitments in recent years [8][12] - Hercules Capital's total investment income has a CAGR of 12.1% over the last decade, with increasing demand for customized financing expected to drive future growth [16][17] - Analysts have revised earnings estimates downward for ARCC, indicating a 12% decline for 2025, while HTGC's earnings are expected to decline by 4% in 2025 but grow by 5.9% in 2026 [26][38] Group 4: Valuation and Comparison - Ares Capital is currently trading at a forward P/E of 10.54X, higher than its five-year median of 9.36X, while Hercules Capital trades at a forward P/E of 8.83X, lower than its five-year median of 9.39X [30][33] - Hercules Capital has a return on equity (ROE) of 16.84%, significantly higher than ARCC's 11.05% and the industry average of 11.20% [33][37] - HTGC's dividend yield of 9.23% is slightly higher than ARCC's 8.92%, although both are below the industry average of 10.27% [35][37]